March 2, 2018 / 12:38 PM / 7 months ago

BRIEF-Reata Pharmaceuticals Inc. Announces Q4 Loss Per Share $0.64

March 2 (Reuters) - Reata Pharmaceuticals Inc:

* REATA PHARMACEUTICALS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL AND OPERATING RESULTS

* Q4 LOSS PER SHARE $0.64

* AS OF DECEMBER 31, 2017, COMPANY HAD $129.8 MILLION IN CASH AND CASH EQUIVALENTS

* REATA PHARMACEUTICALS- BELIEVE EXISTING CASH AND CASH EQUIVALENTS, AVAILABLE DEBT AND EXPECTED MILESTONE WILL BE SUFFICIENT TO FUND INTO H2 2019 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below